← Evidence map

ArticleThe Journal of urology2020

Re: Impact of 5α-Reductase Inhibitor and α-Blocker Therapy for Benign Prostatic Hyperplasia on Prostate Cancer Incidence and Mortality.

Steven A KaplanPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020

2021

this papercites it

Re: Impact of 5α-Reductase Inhibitor and α-Blocker Therapy for Benign Prostatic Hyperplasia on Prostate Cancer Incidence and Mortality. | OpenQuestion